Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
0.2550
-0.0012 (-0.47%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
37
38
Next >
Psychedelic Stock Gainers And Losers From October 12, 2022
October 12, 2022
GAINERS: Allied (OTC:ALID) shares closed up 48.05% at $0.48
Via
Benzinga
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
October 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12
Via
Benzinga
TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day
October 11, 2022
Via
Investor Brand Network
Psychedelic Drugs Prove Their Worth In Clinical Trials
October 11, 2022
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...
Via
PressReach
Psychedelic Stock Gainers And Losers From October 10, 2022
October 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.51% at $0.63 LOSERS:
Via
Benzinga
Cybin & The Chopra Foundation Recognize World Mental Health Day
October 10, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Drug Stocks Index Up Slightly This Week
October 08, 2022
There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD.
Via
Talk Markets
Study Finds Using Social Media May Negatively Affect Youths’ Mental Health
September 21, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From October 6, 2022
October 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) ‘Focused on Adding Targeted IP’
October 06, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Provides Update on its Intellectual Property Portfolio
October 06, 2022
From
Cybin Inc.
Via
Business Wire
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...
Via
PressReach
Topics
Supply Chain
Exposures
Supply Chain
Allied, GH Research Among Top Psychedelic Movers Of Today
October 04, 2022
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
October 03, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58
Via
Benzinga
September Cannabis Category Performances Ranged From -6.3% To -39.0%
October 03, 2022
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September...
Via
Talk Markets
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 30, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49
Via
Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
September 29, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44
Via
Benzinga
Psychedelic Stock Gainers And Losers From September 28, 2022
September 28, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16
Via
Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
September 27, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Enters Agreement to Obtain Novel Catalog of Psychedelic-Based Compounds
September 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.
Via
Benzinga
Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
September 27, 2022
From
Cybin Inc.
Via
Business Wire
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 26, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13
Via
Benzinga
The 5 Cannabis Categories Fell Even Further Last Week
September 26, 2022
The 5 categories in the cannabis sector performed quite differently from each other again last week. The ones that lost least are the most peripheral to the growing and/or distribution of cannabis.
Via
Talk Markets
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
September 25, 2022
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From September 22, 2022
September 22, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10
Via
Benzinga
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City...
Via
PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From September 21, 2022
September 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32
Via
Benzinga
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences
September 21, 2022
Via
Investor Brand Network
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.